Hormone Replacement Therapy Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting hormone replacement therapy clinical trials across 5 countries. Studies span Not Applicable, Phase 4. Top locations include Aarhus, Aarhus N, Denmark, Aurora, Colorado, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Hormone Replacement Therapy Trials at a Glance

7 actively recruiting trials for hormone replacement therapy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Aarhus, Aurora, and Beijing. Lead sponsors running hormone replacement therapy studies include Aarhus University Hospital, Mỹ Đức Hospital, and Peking Union Medical College Hospital.

Browse hormone replacement therapy trials by phase

Treatments under study

About Hormone Replacement Therapy Clinical Trials

Looking for clinical trials for Hormone Replacement Therapy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hormone Replacement Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hormone Replacement Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

InfertilityFrozen Embryo Transfer (FET)Endometrial Peristalsis+4 more
Mỹ Đức Hospital442 enrolled1 locationNCT07675213
Recruiting
Not Applicable

Menopause Effects on Cortico-reticular Functioning

MenopauseHormone Replacement Therapy
University of Jyvaskyla20 enrolled1 locationNCT07500922
Recruiting
Not Applicable

Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

Embryo TransferHormone Replacement TherapyLetrozole+1 more
Mỹ Đức Hospital790 enrolled2 locationsNCT06372119
Recruiting

Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.

Hypogonadotropic HypogonadismPrimary Ovarian InsufficiencyHormone Replacement Therapy
University of Colorado, Denver34 enrolled1 locationNCT06357442
Recruiting
Phase 4

Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

Estrogen DeficiencyTurner SyndromeHypogonadism; Ovarian+2 more
Aarhus University Hospital50 enrolled1 locationNCT06570460
Recruiting
Phase 4

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

Estrogen DeficiencyTurner SyndromeHypogonadism; Ovarian+2 more
Aarhus University Hospital50 enrolled1 locationNCT06544473
Recruiting
Not Applicable

Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage

Neurocritical CareIntracerebral HemorrhageHormone Replacement Therapy+1 more
Peking Union Medical College Hospital100 enrolled1 locationNCT06353555